ArticleHeliyon2024

Plasma levels of chemokines decrease during elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis.

Dirk Westhölter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.